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C910 Original articleOffice and 24-h ambulatory blood pressure control by
treatment in general practice: the ‘Monitoraggio della
pressione ARteriosa nella medicina TErritoriale’ study
Augusto Zaninellia, Gianfranco Paratib, Claudio Cricellic, Angelo A. Bignaminid,
Pietro A. Modestia, Franco Pamparanae, Grzegorz Bilob, Giuseppe Manciab
and Gian F. Gensinia, On behalf of MARTE InvestigatorsBackground Guidelines recommend that blood pressure
(BP) should be lowered in hypertensive patients to prevent
cardiovascular accidents. Management of antihypertensive
treatment by general practitioners is usually based on office
measurements, which may not allow an assessment of BP
control over 24h, which requires ambulatory BP monitoring
(ABPM) to be implemented. This is rarely done in general
practice, and limited information is available on the
consistency between the evaluations of the response to
treatment provided by office measurement and by ABPM in
this setting.
Aim To assess concordance between office BP
measurements and ABPM-based estimates of hypertension
control in a general practice setting.
Design of study Prospective, comparative between
techniques.
Setting General practice.
MethodsSeventy-eight general practices, representative of
all Italian regions, participated in this study by recruiting
sequential hypertensive adults on stabilized treatment, who
were subdivided into even groups with office BP,
respectively, controlled or noncontrolled by treatment. In
each individual, ABPM was applied by the general
practitioner after appropriate training, and 24-h ABP values
were defined as controlled or not according to current
guidelines. Concordance between office and ABPM
evaluation of BP control was assessed with k statistics.
Positive and negative predictive values of office
measurement versus ABPM were estimated.
Results Between July 2005 and November 2006, 190
general practitioners recruited 2059 hypertensive patients
based on office BP measurements; in 1728 patients, a 24-hopyright © Lippincott Williams & Wilkins. Unautho
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as valid for further analysis. The agreement between the
assessment of BP control by office measurement and by
ABPM was poor (kU0.120), with office measurements
showing a satisfactory positive predictive value (0.842) and
a poor negative predictive value (0.278); the situation was
worse in patients with three or more among the following
features: male sex, age of at least 65 years, alcohol
consumption, diabetes, and obesity (negative predictive
valueU0.149).
Conclusion In general practice, the agreement between
assessment of BP control by treatment provided by office
and ambulatory BP measurements is better in patients of
‘uncontrolled’ office BP than in ‘controlled’ office BP
patients. This emphasizes the need for the larger use of out-
of-office BP monitoring in a general practice setting, in
particular, in patients considered as ‘controlled’ during
consultation. J Hypertens 28:910–917 Q 2010 Wolters
Kluwer Health | Lippincott Williams & Wilkins.
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Current hypertension guidelines recommend blood pres-
sure (BP) to be satisfactorily ‘controlled’ to achieve
cardiovascular protection, both in primary and secondary
prevention. This implies the achievement of the ident-
ified BP targets, currently set at levels below 140/
90 mmHg in the office and below 125/80 mmHg overthe 24 h [1–3]. General practitioners are expected to
play a major role in the attempt to achieve BP normal-
ization in hypertensive patients, but the results of their
intervention are often reported as unsuccessful, at least
in Italy [3,4]. Furthermore, focus of general practitioners
is, in most cases, only on office BP measurements
to estimate the degree of hypertension control [5],rized reproduction of this article is prohibited.
DOI:10.1097/HJH.0b013e32833778cc
CMasked hypertension and general practices Zaninelli et al. 911regardless of the increasing evidence on the advantages
carried by use of 24-h ambulatory BP monitoring
(ABPM) in this context [6,7] and of the reports on the
different BP thresholds to be considered with this
approach in relation to cardiovascular risk [8–11]. Only
a limited proportion of hypertensive patients, however,
are managed also by considering the information carried
by ABPM, which is usually applied and interpreted by
cardiologists without the direct involvement of the gen-
eral practitioner [5].
Only a few studies [12–14] have addressed the concor-
dance between office and ABPM assessment of hyper-
tension control, focusing in most cases on the evaluation
of how often patients considered not controlled by the
general practitioner were instead controlled according to
ABPM, with the aim being to reduce the costs of hyper-
tension management. This perspective is based on the
hypothesis that office BP measurements may overesti-
mate uncontrolled hypertension due to a possible ‘white-
coat effect’ [15] or because patients are attending an
unfamiliar environment [16], a possibility apparently
confirmed in previous studies [7,12–14].
Misclassification of hypertensive patients due to the
influence of a ‘white-coat hypertension’ might indeed
result in overtreatment of patients at relatively limited
risk. However, the data obtained from large cohorts seen
by general practitioners in Italy [3,4] and the lower BP
thresholds for hypertension diagnosis recommended
for ABP data [8] seem rather to suggest the occurrence
of an opposite phenomenon, that is, a high number of
hypertensive patients being inadequately managed
because of insufficiently aggressive protocols, thus
remaining at high risk of cardiovascular and cerebro-
vascular accidents.
We therefore deemed it appropriate to experimentally
investigate, in Italian practices, the extent of agreement
between the classification of BP control based on con-
ventional clinic measurements and that derived from
ABPM to explore whether a more systematic use of
ABPM might be needed for the appropriate management
of hypertension by the general practitioner.
Methods
Participants and data collection
One hundred ninety general practicioners distributed
over the Italian territory agreed to participate in this
study. All participating doctors were trained on how to
properly perform ABPM and were informed on its value
in the management of hypertension through educational
courses before entering the study.
Each participating physician recruited a minimum of six
consecutive hypertensive patients on stabilized anti-
hypertensive treatment for at least 6 months, who were
either regarded as well controlled (50%) or not controlledopyright © Lippincott Williams & Wilkins. Unauthby treatment according to the office BP measurement
obtained over the last three visits.
Exclusion criteria were the presence of atrial fibrillation,
any severe systemic or psychiatric disease majorly affect-
ing patients’ health status, or both, or their inability to
reliably perform a 24-h ABP recording.
For each participant who agreed in writing to participate
after receiving adequate information, demographic and
clinical data were collected (age, sex, date of first diag-
nosis of hypertension, history of acute coronary syn-
drome, history of stroke/transient ischemic attack, pre-
sence of hypercholesterolaemia, hypertriglyceridaemia,
diabetes mellitus, and peripheral arterial disease, as
recorded in the practice file; BMI, waist circumference,
alcohol consumption, and smoking habits recorded at
visit). Office BP according to the usual practice pro-
cedures was recorded at the time of the visit in the seated
position, together with information on the current anti-
hypertensive therapy and on any other therapy pre-
scribed. As mentioned above, the patient was then classi-
fied by the attending physician as having a ‘controlled’ or
‘noncontrolled’ hypertension based on the average of the
BP values obtained during last three doctor’s visits.
Subsequently, each patient performed a 24-h ABPM,
making use of the validated A&D TM 2430 device [11].
Measurements were programmed to be taken every
15 min during daytime and every 30 min during the
night-time. The ABPM device was applied in the
physician’s office. The ABPM file, as well as the file
including clinical data, was anonymously transferred by
each doctor to a Core center hosting the study database,
using a validated secure proprietary internet technique
(Hypernet).
Data analysis
Data were analysed by an independent CRO, Hyperphar
Group (Milan, Italy), using SPSS, version 14, for Win-
dows (SPSS Inc., Chicago, Illinois, USA), after checking
the quality of each ABP recording according to the
requirements issued by the Italian Society of Hyperten-
sion [17] and by the European Society of Hypertension
working group on BP monitoring [9]. Patients were
classified as having ABP controlled based on the current
guidelines (average of the daytime awake period <135/
85 mmHg and average of nocturnal sleep time <120/
70 mmHg). Daytime and night-time periods were
defined based on wide fix intervals (07:00–22:00 h, day-
time; 22:00–07:00 h night-time). ABP values higher than
suggested thresholds were taken as to indicate uncon-
trolled ABP [8]. Usual descriptive statistics were used to
analyse the study data; comparisons between subgroups
were performed with the chi square test (polychotomous
nominal), Cochran–Mantel–Haenszel test of the equal-
ity of odds ratios (dichotomous nominal), Mann–Whitney
U-test (continuous variables with nonhomogeneousorized reproduction of this article is prohibited.
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Table 1 Demographic and lifestyle profile of the sample
Variable
Hypertension
controlled (N¼894)
Hypertension not
controlled (N¼874) Total (N¼1768) Statistics
Sex, n women (%) 453 (50.7) 472 (54.0) 925 (52.3) 0.161g
Ethnicity, n white (%)a 889 (99.4) 866 (99.1) 1755 (99.3) 0.386g
Age (years), meanSD [range] 60.611.8 [19–93] 61.512.2 [26–98] 61.112.0 [19–98] 0.120h
Duration of hypertension (months), meanSD [range] 84.568.3 [6–485] 92.674.3 [6–543] 88.571.4 [6–543] 0.033i
BMI (kg/m2), meanSD [range]b 27.44.0 [14.6–44.4]e 28.14.5 [16.4–47.7]f 27.74.3 [14.6–47.7] <0.001i
Obesity, n obese (%)b 208 (23.7)e 258 (30.4)f 466 (27.0) 0.002g
At risk from waist circumferencec 367 (48.1) 414 (56.4) 781 (52.2) 0.001g
Active smoking, n (%)d 120 (13.3) 136 (15.8) 256 (14.7) 0.197g
Alcohol consumption, >2 U/day, n (%)e 38 (4.4) 50 (5.9) 88 (5.1) 0.141g
Nonantihypertensive therapy, n (%) 424 (47.4) 452 (51.7) 876 (49.5) 0.071g
Number of nonantihypertensive drugs, meanSD [range]f 1.91.2 [1–8] 1.91.2 [1–9] 1.91.2 [1–9] 0.809h
a Others, including two Asiatic, two African, nine Hispanic. b Obese:30.0 kg/m2; 17 controlled missing, 23 noncontrolled missing. c At risk:>88 cm if woman,>102 cm if
man; 133 controlled missing, 140 noncontrolled missing. d Fourteen controlled missing, 16 noncontrolled missing. e Twenty-two controlled missing, 31 noncontrolled
missing. f Only among those taking at least one; most frequent: serum lipid reducing agents (19.6% of patients), antithrombotic agents (18.2%), and drugs used in diabetes
(12.7%). g Cochran–Mantel–Haenszel test for the equality of the odds ratio. h Unpaired t-test not assuming equality of variances. i Mann–Whitney U-test.variances), and t-test (continuous variables with homo-
geneous variances). The analyses of agreement between
techniques were performed using k statistics; positive and
negative predictive values (PPV and NPV) were com-
puted using the classification based on ABPM as refer-
ence standard and office BP measurement as test tech-
nique. All reported P values are two-tailed and have
descriptive value only.
The sample size was set at approximately 2000 patients,
with 1500 valid ABPM recordings being required to
estimate with a power of 95% and a b value of less than
0.05, with a degree of discordance between measures of
1% or more.
The study was performed in compliance with the
Declaration of Helsinki, and the protocol, information,
and consent procedures were approved by the Ethics
Committees of the participating institutions. Participat-
ing doctors were trained and certified by the Italian
Society of General Practice and the European School
of General Practice. The study Steering Committeeopyright © Lippincott Williams & Wilkins. Unautho
Table 2 Medical history and antihypertensive medications
Hypertension controlled
(n¼894)
History of acute coronary syndrome, n (%) 64 (7.2)
History of stroke/TIA, n (%) 40 (4.5)
Hypercholesterolaemia, n (%) 305 (34.5)a
Hypertriglyceridaemia, n (%) 131 (14.7)b
PAD, n (%) 20 (2.2)c
Diabetes, n (%) 101 (11.3)
Diuretics, n (%) 380 (42.5)
ACE-inhibitors, n (%) 409 (45.7)
Beta-blockers, n (%) 264 (29.5)
AT-II blockers, n (%) 257 (28.7)
Ca antagonists, n (%) 228 (25.5)
Alpha-blockers, n (%) 76 (8.5)
Therapeutic classes in use, meanSD [range] 1.810.86 [1–5]
Total daily units, meanSD [range] 1.900.96 [1–6]
Last office SBP recorded, meanSD [range] 137.013.3 [97–190]
Last office DBP recorded, meanSD [range] 82.48.5 [50–118]
Last office HR recorded, meanSD [range] 73.79.3 [47–115]
ACE, angiotensin-converting enzyme; AT, anti-thrombin; HR, heart rate; PAD, periphera
missing information. c One missing information. d Cochran–Mantel–Haenszel test forincluded the authors of this paper, and was responsible
for the scientific reliability of the procedures.
Results
Between 1 July 2005 and 27 November 2006, 190 practi-
cioners recruited 2059 patients: 27 physicians recruited
four or less patients, 124 recruited 5–10 patients, and 39
recruited at least 11 patients. Overall, data of 291 patients
were excluded from analysis because these patients
were unable to provide all data required by the protocol
(14 did perform ABPM and were considered in the safety
section). ABPM was performed in 1768 patients, with a
valid 24-h ABP profile being obtained in 1524 of them.
Among the 1768 patients included, 894 (50.6%) were
reported as ‘controlled’; the remaining ones as ‘not
controlled’ based on office BP. Table 1 summarizes
the demographic and lifestyle profile of these patients
and Table 2 summarizes their medical history and anti-
hypertensive medications. As expected, patients with
noncontrolled hypertension included individuals withrized reproduction of this article is prohibited.
Hypertension not controlled
(n¼874) Total (n¼1768) Statistics
66/874 (7.6) 130 (7.4) 0.752d
38/874 (4.3) 78 (4.4) 0.897d
352 (40.4)b 660 (37.4) 0.011d
178 (20.4)b 309 (17.5) 0.002d
34 (3.9)a 54 (3.0) 0.046d
145 (16.6) 246 (13.9) 0.001d
428 (49.0) 808 (45.7) 0.006d
388 (44.4) 797 (45.1) 0.567d
299 (34.2) 563 (31.8) 0.035d
289 (33.1) 546 (30.9) 0.050d
304 (34.8) 532 (30.1) <0.001d
93 (10.6) 169 (9.6) 0.127d
2.061.01 [1–6] 1.930.94 [1–6] <0.001e
2.171.11 [1–7] 2.031.05 [1–7] <0.001e
151.214.9 [80–210] 144.015.8 [80–210] <0.001f
89.29.5 [50–140] 85.89.6 [50–140] <0.001f
75.49.5 [50–120] 74.69.5 [50–120] 0.001f
l arterial disease; TIA, transient ischemic attack. a Two missing information. b Three
the equality of the odds ratio. e Mann–Whitney U-test. f t-test.
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Table 3 Ambulatory blood pressure monitoring data
Controlled (n¼763) Noncontrolled (n¼761) Total (n¼1524) Statistics
Mean 24-h SBP 132.712.8 [101.7–230.3] 139.514.3 [104.2–225.2] 136.114.0 [101.7–230.3] <0.001c
Mean 24-h DBP 78.26.9 [57.2–102.0] 80.88.5 [60.4–110.9] 79.57.9 [57.2–110.9] <0.001c
Mean 24-h HR 71.78.5 [47.0–101.7] 71.68.8 [49.2–102.9 71.68.7 [47.0–102.9] 0.786b
Mean daytime SBP 136.013.0 [103.2–223.8] 142.814.7 [103.1–241.9] 139.414.3 [103.1–241.9] <0.001c
Mean daytime DBP 80.47.6 [59.0–106.6] 83.29.2 [60.1–111.4] 81.88.6 [59.0–111.4] <0.001c
Mean daytime HR 74.59.2 [49.2–107.6] 74.29.4 [51.6–107.4] 74.39.3 [49.2–107.6] 0.471b
Mean night-time SBP 121.017.7 [82.4–226.3] 127.419.1 [85.5–220.4] 124.218.7 [82.4–226.3] <0.001c
Mean night-time DBP 70.19.3 [48.0–108.0] 72.410.1 [48.1–107.8] 71.29.7 [48.0–108.0] <0.001c
Mean night-time HR 62.38.6 [38.5–98.5] 62.69.2 [36.3–99.9] 62.48.9 [36.3–99.9] 0.416b
Nocturnal SBP dropa 15.014.7 [55.1 to þ69.2] 15.516.3 [66.3 to þ65.0] 15.215.5 [66.3 to þ69.2] 0.463c
Nocturnal DBP dropa 10.39.1 [18.9 to þ38.8] 10.99.4 [34.6 to þ44.2] 10.69.2 [34.6 to þ44.2] 0.229b
Nocturnal HR dropa 12.37.3 [14.4 to þ37.3] 11.67.8 [18.9 to þ35.1] 11.97.5 [18.9 to þ37.3] 0.063b
Data are given in meanSD [range]. HR, heart rate. a Difference between mean daytime average and mean night-time average; negative means an increase. b Unpaired
t-test not assuming equality of variances. c Mann–Whitney U-test.significantly greater body weight and waist circumference
than those with controlled hypertension. Furthermore,
they had a significantly longer history of hypertension;
higher proportion of concurrent diseases, especially dia-
betes; and were receiving significantly more antihyper-
tensive agents (especially, diuretics, b-blockers, and Ca
antagonists).
In 244 patients, the 24-h ABP recording was rated as not
valid. High-quality ABPM in a general practice setting
could thus be obtained in 1524 out of 1768 patients in a
per protocol analysis or in 1524 out of 1970 patients
according to an intention-to-treat approach, by including
patients who should have performed ABPM (seen at the
office, no recorded exclusion criteria) but who did not.
The feasibility of ABPM in general practice setting can,
therefore, be estimated as ranging between 77.4% [95%
confidence interval (CI)¼ 75.4–79.2] and 86.2% (95%
CI¼ 84.5–87.8). The proportion of valid ABP recordings
was similar between controlled (85.3%; 95% CI¼ 82.8–opyright © Lippincott Williams & Wilkins. Unauth
Fig. 1
Agreement (all patients) between office and ambulatory blood pressure mon
pressure monitoring.87.6) and noncontrolled patients (87.1%; 95% CI¼ 84.6–
89.2%; P¼ 0.294, Cochran–Mantel–Haenszel test).
Overall, only 332 out of 1524 valid ABP recordings
identified a ‘controlled’ hypertension over 24 h. Out of
the 1192 recordings ‘not controlled’ for ABP, 749 (62.8%)
were not controlled during both day and night; 226
(19.0%) were not controlled during the night but con-
trolled during the day, and 217 (18.2%) were not con-
trolled during the day but controlled during the night
(data not shown). Table 3 summarizes the ABPM data.
The agreement between office and ABPM classification
of BP control was overall poor (k¼ 0.120; Figs 1 and 2). A
patients defined as ‘not controlled’ during the visit by the
attending physician had more than 80% probability to be
found ‘not controlled’ also by 24-h ABPM. On the con-
trary, a patient defined as ‘controlled’ by the attending
physician had more than 70% probability to be found ‘not
controlled’ by ABPM. Among diabetic patients, the latter
proportion increased to almost 75% by considering theorized reproduction of this article is prohibited.
itoring classification of blood pressure control. ABPM, ambulatory blood
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Fig. 2
Agreement (percent) between office and ambulatory blood pressure monitoring classification of blood pressure control. ABPM, ambulatory blood
pressure monitoring.
Table 4 Positive and negative predictive value of office blood
pressure measurement by subgroup
Factor Level PPV NPV
All patients 0.482 0.278
Age (years) <55 0.833 0.290
55–64 0.845 0.304
65 0.847 0.248
Active smokers No 0.850 0.286
Yes 0.800 0.260
Alcohol abusers No 0.842 0.282
Yes 0.911 0.097
Sex Men 0.901 0.243
Women 0.788 0.315
Hypercholesterolaemia No 0.860 0.254
Yes 0.816 0.324
Hypertriglyceridaemia No 0.829 0.280
Yes 0.892 0.275
History of CHD No 0.839 0.278
Yes 0.877 0.271
History of stroke/TIA No 0.841 0.277
Yes 0.871 0.294
PAD No 0.838 0.273
Yes 0.966 0.500
Diabetes No 0.838 0.281
Yes 0.866 0.256
Obese No 0.834 0.288
Yes 0.865 0.251
Risk from abdominal fat No 0.853 0.268
Yes 0.840 0.289
Antihypertensive drugs 1–2 0.853 0.266
3 or more 0.819 0.321
CHD, coronary heart disease; NPV, negative predictive value; PAD, peripheral
arterial disease; PPV, positive predictive value; TIA, transient ischemic attack.same 24-h ABP normalcy cut-off value as in nondiabetic
patients, in absence of more precise guidelines.
Taking 24-h ABP as reference standard, the office
measurement had quite a good PPV (0.842) but a poor
NPV (0.278). Among diabetic patients, the PPV of the
office measurement remained high (0.866) but the NPV
decreased to 0.256.
Specific subgroups of patients, in whom a particularly low
NPV of office BP measurements might be expected, were
identified with the aim of defining conditions in which it
would be appropriate to systematically perform 24-h
ABPM. On the basis of the estimates reported in Table
4, performance of 24-h ABPM appeared indicated mostly
in patients considered ‘controlled’ by the general prac-
titioner, of male sex, at least 65 years of age, drinking
more than 2 U/day of alcohol, obese, or with diabetes.
Among the patients exhibiting three or more among these
five characteristics, the PPV of office BP was 0.914 and
the NPV was 0.149. The patients in this subgroups
represented approximately 12% of the monitored popu-
lation of hypertensive patients on treatment.
Safety
In the present study, 72 patients out of the 1842 who
performed ABPM (of whom 1768 analysed and 74 pro-
tocol violators) prematurely interrupted the recording
(4.0%; 95% CI¼ 3.1–5.0), in 51 of them because of
intolerance or discomfort, in 17 because of technical
problems, and in four because of refusal to complete
the 24-h recording. The total number of undesired reac-
tions, including those not ending in premature test inter-
ruption, amounted to 224 events in 204 patients (11.1%;
95% CI¼ 9.7–12.6).opyright © Lippincott Williams & Wilkins. UnauthoThese events included effects of the compressive action
of the cuff (expressed as pain, local discomfort, topical
reactions from swelling to rash, local haematomas/ecchy-
moses, and hand paraesthesias: 163 events), disturbances
during sleep (54 events), and anxiety or general discom-
fort associated with the procedure (seven events). The
intensity was reported as mild for 120 events, moderaterized reproduction of this article is prohibited.
CMasked hypertension and general practices Zaninelli et al. 915for 80, and severe for 17. The 17 reactions classified as
severe led to premature cuff removal by the patients
(except in three patients) and included pain at com-
pression (in seven), sleep disturbances (in four), topical
reactions (in two), hand paraesthesias (in two), and
anxiety and discomfort (in one each). Corrective actions
by the physician (usually consisting in repositioning of
the cuff) were rarely taken because the onset of the above
reaction was normally not immediate.
Discussion
This study is, to our knowledge, the first nationwide
evaluation of the concordance between the definition
of hypertension control by general practitioners’ based
on conventional BP measurements and the correspond-
ing definition based on data obtained from 24-h ABPM
performed in the same patients. The main result of our
study is that patients found not to be controlled by
conventional BP measurements at the general prac-
titioner’s office were likely to be found so also by 24-h
ABPM, whereas patients found controlled by office BP
measurements were frequently found not controlled
according to ABPM. This discrepancy does not carry
only methodological implications but it is also of sub-
stantial clinical relevance among high-risk patients who
need accurate management of their hypertension.
On theoretical grounds, these findings may lead to the
conclusion that hypertensive patients found ‘controlled’
in the office under antihypertensive treatment should be
considered for 24-h ABPM performance by the general
practitioner based on the expectation that approximately
66% of the hypertensive population may be found ‘not
controlled’ according to ABPM criteria. This theoretical
systematic approach, however, would result in the pre-
scription of a very high number of 24-h ABP recordings
with a significant impact on healthcare costs, also taking
into account the increasing proportion of hypertensive
patients in the population. The findings of our study may
offer a practical solution to this difficulty, however. On
the basis of the search of possible determinants of the
discrepancy between the identification of hypertension
control provided by office and ambulatory BP measure-
ments, our data allow the identification of relatively
small subgroups of hypertensive patients in whom 24-
h ABPM should indeed be performed, aimed at effec-
tively reducing cardiovascular risk. Among hypertensive
patients considered as ‘controlled’ by the general prac-
titioner during the office visit, patients of male sex, aged
at least 65 years, alcohol consumers (>2 U/day), with
obesity and diabetes would in particular need 24-h
ABPM to be performed. This suggestion is based on
the fact that, among the patients carrying three or more of
these five features, the PPV of office BP, in identifying
controlled 24-h ABP values, was 0.914, whereas the
NPV was only 0.149. The patients in this subgroup
represented approximately 12% of the population ofopyright © Lippincott Williams & Wilkins. Unauthhypertensive patients on treatment included in our
study.
An additional finding of our study is related to ABPM
application by general practitioners, who appear able to
obtain valid 24-h ABP recordings in 85% of hypertensive
patients. This performance is not too different from that
reported in specialized centres [9]. It has to be acknow-
ledged, however, that this result may not faithfully reflect
the performance of the ‘average’ general practitioner in
Italy because doctors participating in this study under-
went specific training, which is not usually accessible to
all general practitioners.
A direct comparison with previous similar experiences in
this regard can hardly be made because of the limited
number of studies available on this issue and due to the
change in ABPM evaluation criteria introduced by recent
ABPM guidelines [8,9,17]. In a much smaller cohort in
Ireland (381 patients), 33.8% had a normal BP result on
ABPM [18] compared to the 21.8% seen in the present
study, a finding that may be explained by methodological
differences. Several studies [7,12–14] have been per-
formed to explore the need to reduce treatment intensity
on the assumption that office measurements might be
affected by a substantial ‘white-coat effect’. This con-
dition (i.e. ‘noncontrolled’ patients in the office found
controlled at 24-h ABPM), however, was observed only in
7.9% of patients included in our study, a finding not
substantially different from the data reported in the
literature in a similar setting [19]. Thus, our study
suggests that the condition referred to as ‘white-coat
hypertension’ is infrequently found in general practice,
probably because of the relationship between patients
and their family doctor is significantly different than that
between patients and doctors working in a specialist
clinic. Conversely, a ‘masked hypertension’ condition
is more frequently identified in this setting, which
emphasizes the need to obtain information on out-of-
office BP in a relatively high number of patients. This
could be done either through 24-h ABPM performance or
through a more frequent implementation of home BP
monitoring [20]. Our study was not designed to explore
this issue, but the similarities and differences between
the information on out-of-office BP provided by home
and ABPM is a topic of great interest [21–23], which
would, however, require further investigation in future
studies.
Conclusion
Our study emphasizes the importance of PPV of office
readings in identifying patients with uncontrolled 24-h
BP in general practice. Our data, however, also emphasize
that the finding of controlled office BP in this setting
should be taken with caution because it might not faith-
fully reflect 24-h BP control in daily life. [24] This calls
for a larger use of 24-h ABPM also in clinical practice, and
our study offers some indication on the clinical featuresorized reproduction of this article is prohibited.
C916 Journal of Hypertension 2010, Vol 28 No 5that might help identifying those patients in whom
implementation of this approach can be particularly
useful and may allow a more efficient reduction of BP-
related patient’s cardiovascular risk.
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